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Abstract 
Pyoderma vegetans (PV) is a very rare disorder characterized by erythematous, 
vesiculopustular, exudative, vegetating plaques usually localized in the inguinal and 
axillary folds. The etiology of PV is not known, but it is often associated with bacterial 
infections in immunocompromised patients. Major histopathological features in PV are 
pseudoepitheliomatous hyperplasia and intraepidermal and subepidermal neutrophilic 
or eosinophilic microabscesses. It is well known that these lesions are frequently 
associated with inflammatory bowel diseases, such as ulcerative colitis (UC) and Crohn’s 
disease. No standardized treatment plan is available for PV, although antibiotic 
treatment has often been used, with variable results. The standard first-line therapy is 
still systemic steroids. Herein, we report a case of PV associated with UC with unusual 
localization that showed a good response to systemic corticosteroid, antibiotic and 
sulfasalazine therapy. 
Introduction 
Pyoderma vegetans (PV), is a very rare, chronic inflammatory dermatosis. It is 
characterized by large exudative, verrucous plaques with well-defined and elevated 
borders [1]. PV often affects middle-aged men, is frequently associated with ulcerative 
colitis (UC) and is often difficult to treat [2]. Other diseases that might be linked to this 
condition include cutaneous T-cell lymphoma, primary immunodeficiencies, chronic 
myeloid leukemia, alcoholism, HIV infection and nutritional deficit [2–4]. Predisposing 
factors include microbial infections, halogen ingestion, foreign materials and tattoos in 
patients with a compromised immune system [3]. However, it has also been reported in 
healthy patients [2, 5]. Major histopathological features in PV are pseudoepitheliomatous  
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hyperplasia and intraepidermal and subepidermal neutrophilic or eosinophilic 
microabscesses [6]. 
Here, we present a case report of PV associated with UC and a short review of the 
literature on the therapeutic challenge of this rare disorder. 
Case Report 
A 64-year-old man presented to our clinic with a 1-month history of well-defined, vegetating 
plaques with elevated borders on the fingers of the left hand and on the toes and the medial malleolus of 
the left foot (fig. 1, fig. 2). He had been diagnosed with UC 20 years previously and had been treated 
with sulfasalazine at that time. 
According to the clinical symptoms, uncontrolled, subtotal colectomy was made for UC, which 
resulted in stabilization of the disease without sulfasalazine. However, he had a history of intermittent 
bloody diarrhea and mucus for the following 2 months.  
Laboratory tests revealed a white blood cell count of 12.4 × 10
9 per liter (normal: 4–10 × 10
9), a red 
blood cell count of 3.91 million/μl (normal: 4.2–5.4), hemoglobin 10.6 g/dl (normal: 12–16), hematocrit 
34.1% (normal: 37–47) and a sedimentation rate of 46 mm/h (normal: 0–20). Wound culture was 
positive for Staphylococcus aureus. Fungal culture was negative. Histopathological examination revealed 
marked pseudoepitheliomatous hyperplasia with a dense inflammatory infiltrate composed of 
neutrophils in the upper dermis (fig. 3, fig. 4). Direct immunofluorescence tests were negative. Based 
on these findings, the diagnosis of PV was established. The patient was treated with fluocortolone 60 
mg/day, amoxicillin clavulanate 1 g twice daily and topical wound care with aluminium subacetate 
dressing. Treatment for the relapse of UC was started with sulfasalazine and metronidazole. The skin 
lesions cleared from postinflammatory hyperpigmentation within weeks parallel to the relief of colitis. 
Corticosteroids were gradually tapered and stopped over 8 weeks and the patient was continued on 
sulfasalazine. 
Discussion 
PV, also named blastomycosis-like pyoderma, is a very rare disease. It is referred to as 
‘pyostomatitis vegetans’ when mucosal lesions are observed. It was believed that PV was 
the result of a bacterial invasion in immunosuppressive patients [1]. Because the skin 
lesions usually occur on the trunk and the groin, the remarkably well-defined, vegetating 
plaques with elevated borders on fingers and toes in our case seemed to be an unusual 
clinical presentation. The diagnosis of the disease depends on five criteria which were 
proposed by Su et al. [7]: large verrucous plaques with multiple pustules and elevated 
border, pseudoepitheliomatous hyperplasia with abscesses in tissue biopsy, growth of at 
least one pathogenic bacterium, negative culture for deep fungi, atypical mycobacteria or 
mycobacterium tuberculosis and normal bromide levels. The main pitfall is the risk of 
clinically misdiagnosing this rare condition. Since pemphigus vegetans may show clinical 
and histopathological findings similar to PV, the two are difficult to distinguish from each 
other [4, 6]. The differential diagnosis of PV should include pemphigus vegetans and deep 
fungal infections. Tuberculosis cutis verrucosa, pyoderma gangrenosum, halogenoderma, 
squamous cell carcinoma and Sweet syndrome must also be ruled out [1–3]. To 
differentiate PV from other diseases, evaluations of wound, yeast and mycobacterium 
tuberculosis culture and direct immunofluorescence study must be performed in order to 
rule out pemphigus vegetans. The association of PV with UC is well known but rarely 
reported in literature [2, 3, 6, 8–10]. Since PV is considered a marker of inflammatory  
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bowel disease, a presumptive diagnosis of PV should induce a complete gastrointestinal 
investigation. 
Although numerous treatments have been tried for PV, the condition is usually very 
difficult to treat effectively. The treatment of PV focuses on control of the underlying 
disease. In previously reported cases, the skin lesions regressed after management of 
bowel disease with sulfasalazine, mesalazine or colectomy [3, 8]. Despite the bacterial 
etiology of the lesions in PV, systemic antibiotics alone are no effective treatment [7, 11]. 
Topical application of disodium cromoglycate has been used in the treatment of PV 
which was refractory to antibiotic therapy [12]. The standard first-line therapy is systemic 
steroids at a dose of 0.5 to 1.0 mg/kg. The response to systemic steroids is usually very 
good [11, 13]. Many other treatment modalities, including dapsone, azathioprine, 
cyclosporine and laser debridement, have been reported only anecdotally in case reports 
and are generally accepted as second-line therapies [1, 2, 10, 13]. Besides these therapies, 
topical tacrolimus complementing total colectomy has also been reported to be beneficial 
in cleaning lesions [10]. Carrera et al. [1] also reported a patient with PV and psoriasis 
who was successfully treated with etanercept. Our patient was treated with sulfasalazine 
for UC and with steroid and antibiotic for the cutaneous lesions. 
PV has a good prognosis with therapy. Its evolution tends to follow the progression of 
the underlying intestinal disorder [11]. It is important to be familiar with this vegetative 
skin condition, as correct diagnosis may lead to the uncovering of inflammatory bowel 
disease. The management of PV includes several agents, but definite guidelines are still 
lacking. 
 
 
 
 
 
 
Fig. 1. Circumscribed vegetating plaques with erythematous elevated borders on the toes and medial 
malleolus of the left foot. 
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Fig. 2. Well-defined erythematous, crusted and vegetating plaques on the fingers. 
 
 
 
Fig. 3. Pseudoepitheliomatous hyperplasia with a dense inflammatory infiltrate composed of 
neutrophils was observed in the upper dermis (hematoxylin-eosin staining, ×40). 
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Fig. 4. Eosinophils and neutrophils aggregate to form abscesses in the dermis (hematoxylin-eosin 
staining, ×100). 
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